Erudio Healtherudio.com
Drug
Triptorelin trials: what clinicians said in public
An HCP commentary report on 1 clinical trial studying triptorelin: VA STARPORT. It covers what clinicians said in public about one trial, on podcasts, videos and posts, every statement linked to its source. Below them, 5 more trials with public commentary and no report yet.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| VA STARPORT NCT04787744 · VA Office of Research and Development | oligometastatic prostate cancer | Phase 2/Phase 3 | 119 | 25 | Focused | Oct 29, 2026 | Preview |
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| PREcoopERA NCT05896566 · ETOP IBCSG Partners Foundation DeepView → | premenopausal ER-positive/HER2-negative early breast cancer | Phase 2 | Deep | View | |||
| PREDICT-RT NCT04513717 · NRG Oncology DeepView → | high risk prostate cancer | Phase 3 | Deep | View | |||
| PCS IX NCT02685397 · Sir Mortimer B. Davis - Jewish General Hospital FocusedView → | castration-resistant prostate cancer with oligometastases | Phase 2/Phase 3 | Focused | View | |||
| NCT03678025 NCT03678025 · SWOG Cancer Research Network FocusedView → | Not given | Phase 3 | Focused | View | |||
| INDICATE NCT04423211 · ECOG-ACRIN Cancer Research Group FocusedView → | Not given | Phase 3 | Focused | View | |||